Revive Therapeutics Ltd
XBER:31R
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Revive Therapeutics Ltd
XBER:31R
|
CA |
|
B
|
B&G Foods Inc
DUS:DHR
|
US |
|
R
|
Rokiskio Suris AB
XMUN:YTV
|
LT |
|
E
|
Esprit Holdings Ltd
XMUN:ESHB
|
HK |
|
Yaari Digital Integrated Services Ltd
BSE:533520
|
IN |
|
Z
|
Zanaga Iron Ore Company Ltd
SWB:6ZA
|
GG |
Dividends
Dividend Yield
Revive Therapeutics Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Revive Therapeutics Ltd
Payout Ratio
Revive Therapeutics Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 31R is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
31R Price
Revive Therapeutics Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown |
N/A
|
| Market Capitalization | 10.9m EUR |
| Shares Outstanding | 318 458 751 |
| Percentage of Shares Shorted |
N/A
|
